keyword
https://read.qxmd.com/read/38631776/genitourinary-tract-infections-in-patients-taking-sglt2-inhibitors-jacc-review-topic-of-the-week
#21
REVIEW
Veraprapas Kittipibul, Zachary L Cox, Supavit Chesdachai, Mona Fiuzat, JoAnn Lindenfeld, Robert J Mentz
Sodium-glucose cotransporter-2 inhibitors (SGLT2is) have been shown to reduce adverse cardiovascular events in patients with type 2 diabetes mellitus, all-cause mortality, and heart failure hospitalization in patients with heart failure, as well as adverse renal outcomes. However, concerns regarding the heightened risk of genitourinary (GU) infections, particularly urinary tract infections, remain a significant barrier to their wider adoption. Addressing these misconceptions using existing evidence is needed to ensure proper risk-benefit assessment and optimal utilization of this efficacious therapy...
April 23, 2024: Journal of the American College of Cardiology
https://read.qxmd.com/read/38631711/spatial-comparison-of-molecular-features-associated-with-resistance-to-pembrolizumab-in-bcg-unresponsive-bladder-cancer
#22
JOURNAL ARTICLE
Khyati Meghani, Noah Frydenlund, Yanni Yu, Bonnie Choy, Joshua J Meeks
Intravenous immune checkpoint inhibition achieves a 40% 3-month response in BCG-unresponsive non-muscle invasive bladder cancer (NMIBC) with carcinoma in situ. Yet, only half of the early responders will continue to be disease-free by 12 months, and resistance mechanisms are poorly defined. We performed spatial profiling of BCG-unresponsive tumors from patients responsive or resistant to intravenous pembrolizumab treatment, analyzing samples both before initiating and 3 months post-intravenous pembrolizumab treatment...
April 16, 2024: Journal for Immunotherapy of Cancer
https://read.qxmd.com/read/38631104/real-world-analysis-of-peritoneal-metastasis-from-renal-cell-carcinoma-meet-uro27
#23
JOURNAL ARTICLE
Marco Stellato, Sebastiano Buti, Marco Maruzzo, Maria Bassanelli, Melissa Bersanelli, Marilena Di Napoli, Michele Dionese, Martina Fanelli, Roberto Filippi, Giuseppe Fotia, Luca Galli, Francesco Grillone, Michele Maffezzoli, Brigida Anna Maiorano, Cecilia Nasso, Sara Elena Rebuzzi, Luca Lalli, Giandomenico Roviello, Mariella Sorarù, Bruno Vincenzi, Giuseppe Procopio, Elena Verzoni
BACKGROUND: Peritoneal metastases (PM) have been reported in approximately 1% of patients with metastatic Renal Cell Carcinoma (mRCC). Outcome data are limited due to the rarity of this metastatic site. Therefore, the aim of our study is to describe renal cell carcinoma (RCC) patients with PM treated as per clinical practice. MATERIALS AND METHODS: Baseline characteristics and outcome data of patients with PM from RCC were retrospectively collected from 18 Italian oncological referral centers adhering to the Meet-Uro group, from January 2016 to January 2023...
March 19, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38630382/a-japanese-multi-institutional-phase-ii-study-of-moderate-hypofractionated-intensity-modulated-radiotherapy-with-image-guided-technique-for-prostate-cancer
#24
JOURNAL ARTICLE
Katsumasa Nakamura, Keiji Nihei, Yoshihiro Saito, Naoto Shikama, Shin-Ei Noda, Ryusuke Hara, Toshiyuki Imagumbai, Takashi Mizowaki, Takeshi Akiba, Etsuo Kunieda, Masanori Someya, Saiji Ohga, Jiro Kawamori, Takuyo Kozuka, Yosuke Ota, Koji Inaba, Takeshi Kodaira, Yoshiyuki Itoh, Kouta Funakoshi, Yoshikazu Kagami
BACKGROUND: The aim of this multi-institutional phase II study was to confirm the safety and the potential efficacy of moderately hypofractionated intensity-modulated radiotherapy (IMRT) with prostate-based image-guidance for Japanese patients. METHODS: Patients with low- or intermediate-risk localized prostate cancer were eligible. Patients with a part of high risk (having only one of the following factors, cT3a, 20 < PSA ≤ 30, or GS = 8 or 9) were also included...
April 17, 2024: International Journal of Clinical Oncology
https://read.qxmd.com/read/38629578/understanding-and-overcoming-resistance-to-immunotherapy-in-genitourinary-cancers
#25
REVIEW
Sean T Evans, Yash Jani, Caroline S Jansen, Ahmet Yildirim, Ecem Kalemoglu, Mehmet Asim Bilen
The introduction of novel immunotherapies has significantly transformed the treatment landscape of genitourinary (GU) cancers, even becoming the standard of care in some settings. One such type of immunotherapy, immune checkpoint inhibitors (ICIs) like nivolumab, ipilimumab, pembrolizumab, and atezolizumab play a pivotal role by disturbing signaling pathways that limit the immune system's ability to fight tumor cells. Despite the profound impact of these treatments, not all tumors are responsive. Recent research efforts have been focused on understanding how cancer cells manage to evade the immune response and identifying the possible mechanisms behind resistance to immunotherapy...
December 31, 2024: Cancer Biology & Therapy
https://read.qxmd.com/read/38628781/analysis-of-single-umbilical-artery-with-concurrent-congenital-anomaly-is-it-a-risk-factor-for-poor-prognosis-a-cross-sectional-study
#26
JOURNAL ARTICLE
Na Hyun Lee, Hee Joung Choi
BACKGROUND: A single umbilical artery (SUA) may coexist with a single anomaly or multiple congenital anomalies. Although anomalies associated with SUA can primarily cause high perinatal mortality, their clinical significance has not been evaluated. OBJECTIVE: We investigated the relationship between the clinical features and the type or number of concurrent anomalies in neonates with SUA. MATERIALS AND METHODS: In this cross-sectional study, 104 neonates with SUA were enrolled from January 2000 to December 2020 at Dongsan hospital, Daegu, South Korea...
February 2024: International Journal of Reproductive Biomedicine (Yazd, Iran)
https://read.qxmd.com/read/38626735/primary-results-of-patients-with-genitourinary-malignancies-presented-at-a-molecular-tumor-board
#27
JOURNAL ARTICLE
Jakob Michaelis, Ruth Himmelsbach, Patrick Metzger, Silke Lassmann, Melanie Börries, Martin Werner, Cornelius Miething, Rouven Höfflin, Anna L Illert, Justus Duyster, Heiko Becker, August Sigle, Christian Gratzke, Markus Grabbert
PURPOSE: Personalized medicine poses great opportunities and challenges. While therapeutic landscape markedly expands, descriptions about status, clinical implementation and real-world benefits of precision oncology and molecular tumor boards (MTB) remain sparse, particularly in the field of genitourinary (GU) cancer. Hence, this study characterized urological MTB cases to better understand the potential role of MTB in uro-oncology. METHODS: We analyzed patients with complete data sets being reviewed at an MTB from January 2019 to October 2022, focusing on results of molecular analysis and treatment recommendations...
April 16, 2024: Urologia Internationalis
https://read.qxmd.com/read/38626661/a-randomized-double-blind-placebo-controlled-trial-evaluating-the-effect-of-topical-urea-for-secondary-prophylaxis-of-hand-foot-skin-reaction-in-renal-cell-cancer-patients-on-sunitinib-therapy
#28
JOURNAL ARTICLE
Syed Shariq Naeem, Pooja Gupta, Ranjit Kumar Sahoo, V L Kumar, T Velpandian, Archana Singh, Atul Batra, Raja Pramanik, Sameer Rastogi, Saumya Srivastava
INTRODUCTION: Hand foot skin reaction (HFSR) is a common dose-limiting adverse effect of multi kinase inhibitors (MKI) whose mechanism is not fully understood, and the prophylaxis is inadequate. OBJECTIVE: In this pilot study, a double-blind, randomized placebo-controlled trial was conducted to evaluate the effect of topical urea in secondary prevention of sunitinib-induced HFSR in renal cell cancer patients. METHODS: Out of 55 screened patients, 14 were randomized to receive topical urea or placebo for four weeks...
March 13, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38626660/adrenocortical-cancer-in-the-real-world-a-comprehensive-analysis-of-clinical-features-and-management-from-the-turkish-oncology-group-tog
#29
JOURNAL ARTICLE
Hatime Arzu Yasar, Burak Yasin Aktas, Gokhan Ucar, Sema Sezgin Goksu, Irem Bilgetekin, Burcu Cakar, Abdullah Sakin, Ozturk Ates, Tugba Basoglu, Cagatay Arslan, Atike Gokcen Demiray, Semra Paydas, Irfan Cicin, Mehmet Ali Nahit Sendur, Nuri Karadurmus, Hakan Kosku, Aytuğ Uner, Perran Fulden Yumuk, Gungor Utkan, Umut Kefeli, Ozgur Tanriverdi, Havva Cinkir, Ozge Gumusay, Nazım Serdal Turhal, Serkan Menekse, Engin Kut, Ismail Beypinar, Teoman Sakalar, Hacer Demir, Emre Yekeduz, Saadettin Kilickap, Mustafa Erman, Yuksel Urun
INTRODUCTION: Adrenocortical carcinoma (ACC) is a rare yet highly malignant tumor associated with significant morbidity and mortality. This study aims to delineate the clinical features, survival patterns, and treatment modalities of ACC, providing insights into the disease's prognosis. MATERIALS AND METHODS: A retrospective analysis of 157 ACC patients was performed to assess treatment methodologies, demographic patterns, pathological and clinical attributes, and laboratory results...
March 15, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38623683/study-on-drug-resistance-to-treatment-for-ureaplasma-urealyticum-infections-in-the-female-genital-tract
#30
JOURNAL ARTICLE
Jie Zheng, Yanhui Li, Junpeng Zhao, Jinyin Yan
BACKGROUND: Ureaplasma urealyticum (U. urealyticum) commonly occurs in female genitourinary infections, and its different biovars and serotypes have varying degrees of resistance to different antibiotics. This study aimed to ex-plore the characteristics of U. urealyticum infection and drug-resistant profiles in Chinese females. METHODS: We included 1,045 females with genital tract infections who visited Tangshan Workers' Hospital and Tangshan Maternal and Child Health Center from September 2017 to December 2018...
April 1, 2024: Clinical Laboratory
https://read.qxmd.com/read/38619781/clinical-features-of-prostate-cancer-by-polygenic-risk-score
#31
JOURNAL ARTICLE
Christina Spears, Menglin Xu, Abigail Shoben, Shawn Dason, Amanda Ewart Toland, Lindsey Byrne
Genome-wide association studies have identified more than 290 single nucleotide variants (SNVs) associated with prostate cancer. These SNVs can be combined to generate a Polygenic Risk Score (PRS), which estimates an individual's risk to develop prostate cancer. Identifying individuals at higher risk for prostate cancer using PRS could allow for personalized screening recommendations, improve current screening tools, and potentially result in improved survival rates, but more research is needed before incorporating them into clinical use...
April 15, 2024: Familial Cancer
https://read.qxmd.com/read/38619417/-role-of-nanomaterials-in-the-diagnosis-of-prostate-cancer-an-update
#32
JOURNAL ARTICLE
Chu-Jun Leng, Jun Hu, Song Xu
Prostate cancer (PCa) is one of the most common malignant tumors of the genitourinary system in middle-aged and elderly men. The incidence of PCa has been increasing year by year in China in recent years, posing a major threat to the physical and mental health of Chinese men. With the rapid development of nanotechnology, the research of nanomaterials in biomedicine is increasing, which effectively promotes the application of nanomaterials in the early diagnosis of a variety of tumors, including PCa. This article reviews the latest research progress of nanomaterials in the diagnosis of PCa...
July 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38619416/-application-status-and-prospect-of-mendelian-randomization-analysis-in-the-study-of-prostate-cancer-pathogenesis
#33
JOURNAL ARTICLE
Xin-Yu Xu, Jun Zhou
Prostate cancer is the most common malignant tumor of male genitourinary system, its morbidity and mortality increase year by year, and has become a public health problem affecting male health. Mendelian randomization (MR) analysis has been widely used in epidemiological etiology inference in recent years. Compared with general observational studies, it avoids the interference of confounding factors and has clear causal sequence. The judgment of disease risk factors is more helpful for early intervention and clinical prevention and treatment of diseases...
July 2023: Zhonghua Nan Ke Xue, National Journal of Andrology
https://read.qxmd.com/read/38618952/von-hippel-lindau-tumor-suppressor-controls-m6a-dependent-gene-expression-in-renal-tumorigenesis
#34
JOURNAL ARTICLE
Cheng Zhang, Miaomiao Yu, Austin J Hepperla, Zhao Zhang, Rishi Raj, Hua Zhong, Jin Zhou, Lianxin Hu, Jun Fang, Hongyi Liu, Qian Liang, Liwei Jia, Chengheng Liao, Sichuan Xi, Jeremy M Simon, Kexin Xu, Zhijie Liu, Yunsun Nam, Payal Kapur, Qing Zhang
N6-Methyladenosine (m6A) is the most abundant posttranscriptional modification, and its contribution to cancer evolution has recently been appreciated. Renal cancer is the most common adult genitourinary cancer, approximately 85% of which is accounted for by the clear cell renal cell carcinoma (ccRCC) subtype characterized by VHL loss. However, it is unclear whether VHL loss in ccRCC affects m6A patterns. In this study, we demonstrate that VHL binds and promotes METTL3/METTL14 complex formation while VHL depletion suppresses m6A modification, which is distinctive from its canonical E3 ligase role...
April 15, 2024: Journal of Clinical Investigation
https://read.qxmd.com/read/38617428/association-between-ambient-temperature-and-genitourinary-emergency-ambulance-dispatches-in-japan-a-nationwide-case-crossover-study
#35
JOURNAL ARTICLE
Yasuko Mano, Lei Yuan, Chris Fook Sheng Ng, Masahiro Hashizume
BACKGROUND: Although the effects of temperature on genitourinary morbidity and mortality have been investigated in several countries, it remains largely unexplored in Japan. We investigated the association between ambient temperature and genitourinary emergency ambulance dispatches (EADs) in Japan and the modifying roles of sex, age, and illness severity. METHODS: We conducted a time-stratified case-crossover study with conditional quasi-Poisson regression to estimate the association between mean temperature and genitourinary EADs in all prefectures of Japan between 2015 and 2019...
April 2024: Environmental Epidemiology
https://read.qxmd.com/read/38617006/the-characterization-and-comorbidities-of-heterozygous-bardet-biedl-syndrome-carriers
#36
JOURNAL ARTICLE
Meng-Hua Li, I-Chieh Chen, Hui-Wen Yang, Hsin-Chien Yen, Yung-Chieh Huang, Chia-Chi Hsu, Yi-Ming Chen, Yu-Yuan Ke
Introduction: Bardet-Biedl syndrome (BBS) is a rare autosomal recessive disorder with clinical features of retinal dystrophy, obesity, postaxial polydactyly, renal anomalies, learning disabilities, hypogonadism, and genitourinary abnormalities. Nevertheless, previous studies on the phenotypic traits of BBS heterozygous carriers have generated inconclusive results. The aim of our study was to investigate the impact of BBS heterozygosity on carriers when compared to non-carriers within the Taiwanese population...
2024: International Journal of Medical Sciences
https://read.qxmd.com/read/38616147/clinical-outcomes-and-prognostic-factors-in-patients-with-penile-carcinoma-a-sub-analysis-from-meet-uro-23-i-rare-registry-study
#37
JOURNAL ARTICLE
Veronica Mollica, Francesco Massari, Marco Maruzzo, Davide Bimbatti, Melanie Claps, Brigida Anna Maiorano, Maria Giuseppa Vitale, Roberto Iacovelli, Paola Ermacora, Giandomenico Roviello, Fabio Calabrò, Orazio Caffo, Francesca Vignani, Francesco Grillone, Francesco Pierantoni, Marilena Di Napoli, Alessia Mennitto, Andrea Marchetti, Alvise Mattana, Alessia Cavo, Maria Bassanelli, Luigi Formisano, Veronica Prati, Giulia Claire Giudice, Sebastiano Buti
INTRODUCTION: Penile squamous cell carcinoma (PSCC) is a rare tumor with an aggressive behavior. The Meet-URO 23/I-RARE registry includes rare genitourinary malignancies. We extracted patients with PSCC to conduct a retrospective study aimed at assessing clinical outcomes and prognostic factors. PATIENTS AND METHODS: Primary endpoints were overall survival and progression-free survival. Prognostic factors for OS and PFS were analyzed using univariate and multivariate analysis...
March 18, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38615487/nlr-outperforms-low-hemoglobin-and-high-platelet-count-as-predictive-and-prognostic-biomarker-in-metastatic-renal-cell-carcinoma-treated-with-immune-checkpoint-inhibitors
#38
JOURNAL ARTICLE
Matthew Young, Jose C Tapia, Bernadett Szabados, Agne Jovaisaite, Francesca Jackson-Spence, Elizabeth Nally, Thomas Powles
BACKGROUND: Reliable biomarkers in renal cell carcinoma (RCC) remain elusive. While several markers have been shown to be associated with prognosis, and may aid in risk assessment, predictive biomarkers of response to immune checkpoint inhibitors (ICIs) have not been established. Previous studies have shown that a high pretreatment neutrophil-lymphocyte ratio (NLR) is a negative prognostic factor in RCC. However, a clinically useful cut-off for the predictive and prognostic value of NLR has not been well defined...
March 8, 2024: Clinical Genitourinary Cancer
https://read.qxmd.com/read/38614996/single-port-robotic-assisted-laparoscopic-synchronous-surgery-in-pediatric-patent-processus-vaginalis
#39
JOURNAL ARTICLE
Geng Li, Heyun Gao, Shanzhen Yu, Yunkai Guo, Tao Hu, Yifan Liu, Guowei Du, Guangbin Huang, Wen Zhang
PURPOSE: Patent processus vaginalis (PPV) is usually observed in pediatric abdominal surgery; however, robotic single-port surgery in repairing processus vaginalis has not been reported in children. Herein, we present our clinical experiences in single-port robotic surgeries for PPV repair to evaluate both efficacy and safety. METHODS: Retrospective analysis of patients underwent single-port robotic-assisted laparoscopic surgery for genitourinary diseases from May 2020 and May 2023 in our center...
April 13, 2024: BMC Surgery
https://read.qxmd.com/read/38614853/impact-of-preoperative-plasma-potassium-levels-on-oncological-outcomes-major-complications-and-30-day-mortality-in-bladder-cancer-patients-undergoing-radical-cystectomy
#40
JOURNAL ARTICLE
Jakob Klemm, Shahrokh F Shariat, Ekaterina Laukhtina, Pawel Rajwa, Malte W Vetterlein, Victor M Schuettfort, Markus von Deimling, Roland Dahlem, Margit Fisch, Michael Rink
INTRODUCTION AND OBJECTIVES: We examined the impact of preoperative plasma potassium levels (PPLs) on outcomes in patients undergoing radical cystectomy (RC) for urothelial carcinoma of the bladder (UCB), hypothesizing that potassium imbalances might influence outcomes. PATIENTS AND METHODS: In this retrospective study, 501 UCB patients undergoing RC from 2009 to 2017 at a tertiary center were analyzed. Blood samples collected a week prior to surgery defined normal and abnormal PPL based on institutional standards...
March 21, 2024: Clinical Genitourinary Cancer
keyword
keyword
57761
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.